ScienceDaily (2010-05-31) -- Researchers have identified a biomarker in patient blood which can predict the severity of breast cancer in patients and may enable clinicians to track patients throughout the course of their treatment.
研究團隊發現生化標記,可藉以標定乳癌的嚴重程度,且可臨床醫師追蹤整個治療過程中病人的狀況。
維基上的乳癌
Journal Reference:
M. McIlroy, D. McCartan, S. Early, P. O Gaora, S. Pennington, A. D.K. Hill, L. S. Young. Interaction of Developmental Transcription Factor HOXC11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer. Cancer Research, 2010; 70 (4): 1585 DOI: 10.1158/0008-5472.CAN-09-3713
No comments:
Post a Comment